Dr. Kaplan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
10 Center Drive
Bethesda, MD 20817
Education & Training
Geisel School of Medicine at DartmouthClass of 1998
Certifications & Licensure
NY State Medical License 2001 - 2025
Clinical Trials
- Comprehensive Omics Analysis of Pediatric Solid Tumors and Establishment of a Repository for Related Biological Studies Start of enrollment: 2010 Apr 21
- Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ... Start of enrollment: 2015 Apr 29
- Testing a New Immune Cell Therapy, GD2-Targeted Modified T-cells (GD2CART), in Children, Adolescents, and Young Adults With Relapsed/Refractory Osteosarcoma and Neuroblastoma, The GD2-CAR PERSIST Trial Start of enrollment: 2022 Jan 25
Publications & Presentations
PubMed
- How the bone microenvironment shapes the pre-metastatic niche and metastasis.Kailey N Jackett, Alice T Browne, Etan R Aber, Miranda Clements, Rosandra N Kaplan
Nature Cancer. 2024-12-13 - 6 citationsWhy do patients with cancer die?Adrienne Boire, Katy Burke, Thomas R Cox, Theresa Guise, Mariam Jamal-Hanjani
Nature Reviews. Cancer. 2024-08-01 - 19 citationsImmune determinants of CAR-T cell expansion in solid tumor patients receiving GD2 CAR-T cell therapy.Sabina Kaczanowska, Tara Murty, Ahmad Alimadadi, Cristina F Contreras, Caroline Duault
Cancer Cell. 2024-01-08
Press Mentions
4 Reasons We Haven’t Cured Cancer YetNovember 28th, 2017
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
